These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 14690142)

  • 1. Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening.
    Gehrke T; Sers C; Morawietz L; Fernahl G; Neidel J; Frommelt L; Krenn V
    Scand J Rheumatol; 2003; 32(5):287-94. PubMed ID: 14690142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
    Mandelin J; Li TF; Hukkanen M; Liljeström M; Salo J; Santavirta S; Konttinen YT
    J Rheumatol; 2005 Apr; 32(4):713-20. PubMed ID: 15801030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis.
    Granchi D; Pellacani A; Spina M; Cenni E; Savarino LM; Baldini N; Giunti A
    J Bone Joint Surg Am; 2006 Jul; 88(7):1501-9. PubMed ID: 16818976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin.
    Crotti TN; Smith MD; Findlay DM; Zreiqat H; Ahern MJ; Weedon H; Hatzinikolous G; Capone M; Holding C; Haynes DR
    Biomaterials; 2004 Feb; 25(4):565-73. PubMed ID: 14607494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis.
    Ritchlin CT; Schwarz EM; O'Keefe RJ; Looney RJ
    J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):276-84. PubMed ID: 15615495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of RANKL/RANK/OPG system in the canine model of hip periprosthetic infection osteolysis.
    Zhang HW; Peng L; Li WB; Song KG
    Int J Artif Organs; 2017 Feb; 39(12):619-624. PubMed ID: 28127738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
    Evans CE; Mylchreest S; Andrew JG
    BMC Musculoskelet Disord; 2006 Mar; 7():21. PubMed ID: 16519799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the RANKL/RANK/OPG System in Periprosthetic Osteolysis with Septic Loosening.
    Wang L; Dai Z; Xie J; Liao H; Lv C; Hu Y
    Inflammation; 2016 Feb; 39(1):218-227. PubMed ID: 26294373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis.
    Grimaud E; Soubigou L; Couillaud S; Coipeau P; Moreau A; Passuti N; Gouin F; Redini F; Heymann D
    Am J Pathol; 2003 Nov; 163(5):2021-31. PubMed ID: 14578201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EXPRESSION OF RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-κB LIGAND IN PERIPHERAL BLOOD OF PATIENTS WITH ASEPTIC LOOSENING OF THE IMPLANT AFTER TOTAL HIP APTHROPLASTY].
    Hou K; Wang Y; Lu X; Yang K; Kong W; Li Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jul; 28(7):853-6. PubMed ID: 26462349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct gene expression of receptor activator of nuclear factor-kappaB and rank ligand in the inflammatory response to variant morphologies of UHMWPE particles.
    Ren W; Yang SY; Fang HW; Hsu S; Wooley PH
    Biomaterials; 2003 Nov; 24(26):4819-26. PubMed ID: 14530078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation.
    Mandelin J; Liljeström M; Li TF; Ainola M; Hukkanen M; Salo J; Santavirta S; Konttinen YT
    J Biomed Mater Res B Appl Biomater; 2005 Jul; 74(1):582-8. PubMed ID: 15768436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages.
    Itonaga I; Sabokbar A; Murray DW; Athanasou NA
    Ann Rheum Dis; 2000 Jan; 59(1):26-31. PubMed ID: 10627423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis.
    Haynes DR; Crotti TN; Potter AE; Loric M; Atkins GJ; Howie DW; Findlay DM
    J Bone Joint Surg Br; 2001 Aug; 83(6):902-11. PubMed ID: 11521937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
    Komuro H; Olee T; Kühn K; Quach J; Brinson DC; Shikhman A; Valbracht J; Creighton-Achermann L; Lotz M
    Arthritis Rheum; 2001 Dec; 44(12):2768-76. PubMed ID: 11762937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
    Ma G; Ainola M; Liljeström M; Santavirta S; Poduval P; Zhao D; Chen T; Konttinen YT
    J Rheumatol; 2005 Oct; 32(10):1943-50. PubMed ID: 16206351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement.
    Mandelin J; Li TF; Liljeström M; Kroon ME; Hanemaaijer R; Santavirta S; Konttinen YT
    J Bone Joint Surg Br; 2003 Nov; 85(8):1196-201. PubMed ID: 14653607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.
    Atkins GJ; Bouralexis S; Haynes DR; Graves SE; Geary SM; Evdokiou A; Zannettino AC; Hay S; Findlay DM
    Bone; 2001 Apr; 28(4):370-7. PubMed ID: 11336917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
    Lubberts E; van den Bersselaar L; Oppers-Walgreen B; Schwarzenberger P; Coenen-de Roo CJ; Kolls JK; Joosten LA; van den Berg WB
    J Immunol; 2003 Mar; 170(5):2655-62. PubMed ID: 12594294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening.
    Sabokbar A; Itonaga I; Sun SG; Kudo O; Athanasou NA
    J Orthop Res; 2005 May; 23(3):511-9. PubMed ID: 15885469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.